GAO: GDUFA Approvals are Faster, but FDA Lacks Plan for Extra Fees

Generic Line
A A
The FDA surpassed many of its performance goals for generic drug applications through 2016, but the agency needs a plan for the user fees collected but not spent in the same year, according to the GAO.

To View This Article:

Login

Subscribe To Generic Line